FCF Margin % is calculated as Free Cash Flow divided by its Revenue. AtriCure's Free Cash Flow for the
three
months ended in Mar. 2024 was $-23.8 Mil. AtriCure's Revenue for the
three
months ended in Mar. 2024 was $108.9 Mil. Therefore, AtriCure's FCF Margin % for the quarter that ended in Mar. 2024 was -21.86%.
The historical rank and industry rank for AtriCure's FCF Margin % or its related term are showing as below:
ATRC'
s FCF Margin % Range Over the Past 10 Years
Min: -28.67 Med: -11.97 Max: -5.15
Current: -13.2
During the past 13 years, the highest FCF Margin % of AtriCure was -5.15%. The lowest was -28.67%. And the median was -11.97%.
ATRC's FCF Margin % is ranked worse than 55.34% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: -7.13
vs ATRC: -13.20
AtriCure FCF Margin % Historical Data
The historical data trend for AtriCure's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, AtriCure's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AtriCure's FCF Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AtriCure's FCF Margin % distribution charts can be found below:
* The bar in red indicates where AtriCure's FCF Margin % falls into.
AtriCure FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
AtriCure's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AtriCure FCF Margin % Related Terms
Thank you for viewing the detailed overview of AtriCure's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ATRC has been successfully added to your 